Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

January 31, 2027

Study Completion Date

June 30, 2029

Conditions

Triple Negative Breast Cancer

Interventions

DEVICE

Cryoablation

Tumor ablation before neoadjuvant chemotherapy

COMBINATION_PRODUCT

Cryoablation combined with PD1 Inhibitor

Combination of cryoablation with PD1 inhibitor before neoadjuvant chemotherapy

All Listed Sponsors

lead

Texas Tech University Health Sciences Center

OTHER